4.5 Review

Caffeine in the management of patients with headache

Journal

JOURNAL OF HEADACHE AND PAIN
Volume 18, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s10194-017-0806-2

Keywords

Tension-type headache; Migraine; Caffeine; Acetaminophen; Acetylsalicylic acid; Ibuprofen

Funding

  1. Alder
  2. Allergan
  3. Amgen
  4. Electrocore
  5. eNeura
  6. Boston Scientific
  7. Bristol Meyers Squibb
  8. Teva
  9. Eli Lilly
  10. Vedanta
  11. Dr. Reddys
  12. Novartis
  13. Migraine Research Fund
  14. National Headache Foundation
  15. National Institute of Health
  16. Almirall
  17. AstraZeneca
  18. Bayer
  19. GlaskoSmithKline
  20. Janssen-Cilag
  21. MSD
  22. Pfizer
  23. German Science Council
  24. German Secretary of Education
  25. European Union
  26. eNeura, Inc.

Ask authors/readers for more resources

Caffeinated headache medications, either alone or in combination with other treatments, are widely used by patients with headache. Clinicians should be familiar with their use as well as the chemistry, pharmacology, dietary and medical sources, clinical benefits, and potential safety issues of caffeine. In this review, we consider the role of caffeine in the over-the-counter treatment of headache. The MEDLINE and Cochrane databases were searched by combining caffeine with the terms headache, migraine, and tension-type. Studies that were not placebo-controlled or that involved medications available only with a prescription, as well as those not assessing patients with migraine and/or tension-type headache (TTH), were excluded. Compared with analgesic medication alone, combinations of caffeine with analgesic medications, including acetaminophen, acetylsalicylic acid, and ibuprofen, showed significantly improved efficacy in the treatment of patients with TTH or migraine, with favorable tolerability in the vast majority of patients. The most common adverse events were nervousness (6.5%), nausea (4.3%), abdominal pain/discomfort (4.1%), and dizziness (3.2%). This review provides evidence for the role of caffeine as an analgesic adjuvant in the acute treatment of primary headache with over-the-counter drugs, caffeine doses of 130 mg enhance the efficacy of analgesics in TTH and doses of >= 100 mg enhance benefits in migraine. Additional studies are needed to assess the relationship between caffeine dosing and clinical benefits in patients with TTH and migraine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available